With markets at elevated multiples in May 2026, low share prices can mislead investors into thinking quality is out of reach. Stocks trading below $30 with strong balance sheets offer income, deleveraging stories, or growth at valuations that build in a margin of safety.
Here are five stocks trading under $30 that pair solid books with a credible upside case.
Pfizer (NYSE: PFE)
Pfizer (NYSE:PFE | PFE Price Prediction) is a global biopharma whose portfolio spans immunology, oncology, cardiology, and vaccines, anchored by Eliquis, Prevnar, and the Comirnaty/Paxlovid COVID franchise.
Shares last traded at $25.33, below the 52-week high of $28.28, with a 6.68% dividend yield and a forward P/E of 9x. Q4 2025 adjusted EPS of $0.66 beat the $0.57 estimate, and the consensus analyst target sits at $29.19.
The bull case rests on 9% operational lift in the non-COVID portfolio, the Metsera-driven obesity pipeline, and insider conviction: CEO Albert Bourla and 11 directors acquired phantom stock units at $26.67 on April 23, 2026.
Key risk is a $1.5B revenue headwind from 2026 loss of exclusivity combined with MFN drug pricing pressure. The yield-supported setup has management backing the thesis.
AT&T (NYSE: T)
AT&T (NYSE:T) is the second-largest US wireless carrier, pairing 5G with a rapidly expanding fiber footprint.
At $24.43, shares carry a forward P/E of 11x and a 4.5% dividend yield. Q1 2026 adjusted EPS came in at $0.57 (+11.8% YoY) on revenue of $31.51B. Analyst target: $30.37.
The bull case is execution and cash. AT&T added 584,000 internet customers in Q1 2026, plans $45B in shareholder returns through 2028, and lifted cash to $18.2B at year-end 2025 from $3.3B a year earlier.
Risks include total debt of $173.99B and legacy wireline declines exceeding 20% in 2026. Converged connectivity plus growing free cash flow makes the dividend durable.
SoFi Technologies (NASDAQ: SOFI)
SoFi Technologies (NASDAQ:SOFI) is a digital financial services company holding a national bank charter and the Galileo technology platform.
At $15.71, shares are down 39.99% YTD, even after Q1 2026 produced net income of $166.7M (+134% YoY) and record originations of $12.18B (+68% YoY). Forward P/E is 26x; analyst target $21.10.
The bull case: shareholder equity reached $10.81B while total debt fell from $3.2B to $1.8B over the prior year. CEO Anthony Noto bought 15,545 shares at $16.00 on May 11, 2026 after purchasing 56,000 shares at $17.88 on March 2, 2026.
Risks include personal loan charge-offs at 3.03% and a 27% decline in Technology Platform revenue after a large client departure. The pullback has reset expectations into the growth runway.
Kinross Gold (NYSE: KGC)
Kinross Gold (NYSE:KGC) operates gold mines across the US, Brazil, Chile, and Mauritania.
Shares slipped under $30 to $28.51 after an 18.4% one-month pullback, even as the stock remains up 109.22% over one year. Forward P/E sits at 11x against an analyst target of $40.55. Q1 2026 adjusted EPS hit $0.71 on revenue of $2.41B (+61% YoY), with free cash flow of $837.5M.
The balance sheet is pristine: $2.19B in cash against only $3.66B in total liabilities, plus record 2025 FCF of $2.47B and $255.1M of Q1 buybacks.
Primary risk is gold price volatility and geopolitical exposure. The recent pullback creates a window for investors seeking operating leverage to bullion.
KeyCorp (NYSE: KEY)
KeyCorp (NYSE:KEY) is a Cleveland-based regional bank serving consumer and commercial clients alongside KeyBanc Capital Markets.
At $21.07, KEY trades at a forward P/E of 12x with a 3.89% dividend yield. Q1 2026 EPS of $0.44 beat the $0.4073 estimate, NIM expanded 29 basis points YoY to 2.87%, and ROTCE topped 13%. Analyst target: $24.97.
Management raised 2026 net interest income guidance to 9-10%, plans $1.3B+ in buybacks, and targets 15%+ ROTCE by year-end 2027.
Watch item: nonperforming assets ticked up to 63 bps from 59 bps. A rising-margin franchise returning capital at scale supports the thesis here.
Bottom Line
A share price below $30 is no substitute for diligence. Each name carries identifiable risks alongside balance sheet strengths. Investors should size positions to their risk tolerance and verify the latest disclosures before acting.
Top Gaining Stocks
Top Losing Stocks